CompletedPhase 1NCT02999399

Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism

To determine whether glucobrassicin-rich Brussels sprouts can favorably modify the metabolism of the polycyclic aromatic hydrocarbon deuterated phenanthrene (\[D10\]phe) in current and former smokers

Checked against the public recordLast updated Feb 17, 2023 · Source: ClinicalTrials.gov

StatusCompleted
PhasePhase 1
U.S. locations1
SponsorMasonic Cancer Center, University of Minnesota
01
Study overview

What this study is about

Purpose
Basic Science
Study type
Interventional
Phase
Phase 1
Sponsor
Masonic Cancer Center, University of Minnesota
Interventions being studied
Other: Brussel Sprouts; Drug: Deuterated Phenanthrene
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Adult ≥ 18 years old * Current or former smoker by self-report * Willing to abstain from cruciferous vegetable consumption other than the study vegetable during the study period * Able to understand the experimental nature of the study and provide informed consent * Negative urine pregnancy test for women of childbearing potential within 7 days of baseline \[D10\]phe dosing Exclusion Criteria: * Chronic proton pump inhibitor, H2-blocker (i.e., ranitidine, famotidine), and/or calcium carbonate use * History of gastric bypass surgery, gastric banding, bowel resection, malabsorption syndromes such as celiac sprue or pancreatic insufficiency, or other conditions that may affect gastric absorption * Current use of tobacco products other than cigarettes (i.e. snuff, snuz, smokeless tobacco, cigars, pipes) or use of these products within 3 months of study registration * Major or chronic medical disease, including heart disease, poorly controlled diabetes, etc., to be adjudicated by the principal investigator * Women who are pregnant, intend to become pregnant within 3 months of the study period, or who are breastfeeding * Current or recent (within 12 months) problems with drug use or alcohol dependence by self-report Antibiotic use within 2 months of study enrollment or during the study by self-report Alcohol dependence, abuse, or history of dependence/abuse by self-report Vegetarians * History of respiratory tract cancer * Use of metronidazole or antabuse during the study * Taking ibuprofen, naproxen, other NSAIDs, steroids (except inhaled steroids) within 14 days of study registration * Allergy to Brussels sprouts

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of MinnesotaMinneapolis, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2023. Always confirm current availability with the study team.

View original record ↗